SFI
IRD

Susquehanna Fundamental Investments’s Opus Genetics IRD Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,105
Closed -$30K – 1535
2022
Q3 		$30K Buy
+15,105
New +$32.6K ﹤0.01% 1388
2022
Q1 		$84K Sell
26,055
-191
-0.7% -$654 ﹤0.01% 1469
2021
Q4 		$98K Buy
26,246
+7,205
+38% +$28.9K ﹤0.01% 1336
2021
Q3 		$98K Buy
19,041
+2,600
+16% +$12K ﹤0.01% 1626
2021
Q2 		$87K Buy
+16,441
New +$81.6K ﹤0.01% 1581

Other funds holding IRD

RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's IRD Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Opus Genetics (IRD) in Q4 2022, closing a stake of 15,105 shares — an estimated $30K sold.

Susquehanna Fundamental Investments first reported a position in IRD in Q2 2021 and held it in 5 quarters. The position peaked at $98K in Q4 2021. 35 funds tracked by Wall St. Rank hold IRD as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Opus Genetics position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 15,105 Opus Genetics shares in Q4 2022, an estimated $30K.
  • Susquehanna Fundamental Investments first reported a position in Opus Genetics in Q2 2021 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Opus Genetics position peaked at $98K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.